SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons sharp move is drawing attention after Morgan Stanley named it a top pick, citing accelerating AWS growth and AI opportunities; traders are also pointing to Amazons Trainium software announcement as a potential boost to cloud-chip adoption. The reaction is broadly bullish, though some remain cautious about heavy AI capital spending and whether the gains will hold.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Reports of Lundbecks interest in acquiring Xeris have fueled heavy-volume trading and takeover speculation, though the company has said it is not for sale and no deal is confirmed. Traders are split between expecting further buyer interest and viewing the chatter as unsubstantiated, while some point to Recorlev growth and XP-8121s pipeline potential as standalone reasons for optimism.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine shares surged after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, supporting a planned FDA resubmission. Traders are debating whether the move can continue, with some citing short-squeeze potential and others warning of profit-taking, safety concerns around dizziness, and the fact that FDA approval is still pending.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Recent open-market purchases by Celsius executives and directors have fueled bullish discussion around the shares, while skeptics question whether the buys signal durable confidence given concerns about the core brands sales and management execution. Traders also revive speculation about a Pepsi buyout, but no deal is confirmed.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Anticipation of Vicors Q3 earnings is driving discussion after the company raised its sequential growth outlook twice, with traders pointing to higher royalties from its Vertical Power Delivery licensing. Bulls expect the stronger outlook to show up in results, while others are wary of the sharp pullback and volatility despite the guidance increases.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix shares are under pressure as EyePoints failed wet-AMD trial has heightened doubts about TKI-based treatments, prompting traders to question whether those concerns could extend to Oculars AXPAXLI program. Some investors view the selloff as spillover from a competitors results, while others cite clinical uncertainty and the departure of Oculars chief strategy officer as additional concerns.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

The FDA-cleared expansion of Alpha Taus REGAIN trial in recurrent glioblastoma is a key focus, alongside planned trial data at SNO 2026. Traders are optimistic about early local-control results, while some note that they come from a small initial cohort; the completed enrollment of the pancreatic IMPACT study is another pipeline catalyst discussed.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

A stronger-than-guided Q3 report and an upbeat 2027 EBITDA outlook are driving CLFs rally. Bulls see improving steel prices and earnings potential, while skeptics warn that debt and the reliance on favorable price forecasts could limit the recovery; traders are also debating whether the move will hold or fade as a sell-the-news rally.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras steep post-IPO decline dominates discussion, with traders pointing to insider selling and upcoming share unlocks alongside concerns about valuation, scaling and reliance on OpenAI amid weakness across AI stocks. Some see the selloff as an oversold buying opportunity and are averaging in, while others expect further downside.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ rebounded as technology and AI stocks recovered from a sharp selloff, with traders debating whether the move marks a durable recovery or a low-volume bull trap. Upcoming megacap earnings and AI spending plans are a key focus for the tech-heavy index.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nasdaq Posts Worst Weekly Drop in Months as Dow Edges to a Narrow Gain

Nasdaq Posts Worst Weekly Drop in Months as Dow Edges to a Narrow Gain Nasdaq Posts Worst Weekly Drop in Months as Dow Edges to a Narrow GainPR NewswireVANCOUVER, BC, Oct. 16, 2026 VANCOUVER, BC, Oct. 16, 2026 /PRNewswire/ -- Stock Preachers News Commentary - Wall Street closed a volatile week...

BERETTA HOLDING S.A. ANNOUNCES PRELIMINARY RESULTS OF CASH TENDER OFFER FOR SHARES OF STURM, RUGER & COMPANY, INC.

BERETTA HOLDING S.A. ANNOUNCES PRELIMINARY RESULTS OF CASH TENDER OFFER FOR SHARES OF STURM, RUGER & COMPANY, INC. BERETTA HOLDING S.A. ANNOUNCES PRELIMINARY RESULTS OF CASH TENDER OFFER FOR SHARES OF STURM, RUGER & COMPANY, INC.PR NewswireLUXEMBOURG, Oct. 16, 2026 LUXEMBOURG, Oct. 16, 2026...

BERETTA HOLDING S.A. COMMENCES CASH TENDER OFFER FOR SHARES OF STURM, RUGER & COMPANY, INC. FOR $44.80 PER SHARE

BERETTA HOLDING S.A. COMMENCES CASH TENDER OFFER FOR SHARES OF STURM, RUGER & COMPANY, INC. FOR $44.80 PER SHARE BERETTA HOLDING S.A. COMMENCES CASH TENDER OFFER FOR SHARES OF STURM, RUGER & COMPANY, INC. FOR $44.80 PER SHAREPR NewswireLUXEMBOURG, Sept. 17, 2026 LUXEMBOURG, Sept. 17, 2026...

Ruger Provides Update on Strategic Cooperation Agreement with Beretta Holding

Sturm, Ruger & Company, Inc. (NYSE: RGR) (Ruger or the Company) today announced that the applicable regulatory conditions under its previously announced Strategic Cooperation Agreement (Agreement) with Beretta Holding S.A. (Beretta Holding) have been satisfied. Therefore, consistent with the terms...

Notable Two Hundred Day Moving Average Cross - RGR

In trading on Thursday, shares of Sturm, Ruger & Co., Inc. (Symbol: RGR) crossed below their 200 day moving average of $37.65, changing hands as low as $36.99 per share. Sturm, Ruger & Co., Inc. shares are currently trading down about 2.2% on the day. The chart below s...

Sturm, Ruger & Company, Inc. Reports Second Quarter 2026 Results

Sturm, Ruger & Company, Inc. (NYSE: RGR) (Ruger or the Company) announced today its financial results for the second quarter 2026. Second Quarter 2026 Financial Highlights The Company achieved net sales of $158.1 million, a 19% increase over the $132.5 million achieved in the corresponding period...

Sturm, Ruger & Company, Inc. to Report Second Quarter 2026 Financial Results on Wednesday, July 29

Sturm, Ruger & Company, Inc. (NYSE: RGR) will announce its financial results for the second quarter 2026 and file its Quarterly Report on Form 10-Q on Wednesday, July 29, 2026, after the close of the stock market. That evening, Sturm, Ruger will host a webcast at 4:30 p.m. ET to discuss the second...

RGR Crosses Below Key Moving Average Level

In trading on Monday, shares of Sturm, Ruger & Co., Inc. (Symbol: RGR) crossed below their 200 day moving average of $37.74, changing hands as low as $37.33 per share. Sturm, Ruger & Co., Inc. shares are currently trading down about 3.8% on the day. The chart below sho...

Sturm, Ruger & Company Posts Lower Net Income In Q1

(RTTNews) - Wednesday, Sturm, Ruger & Company, Inc. (RGR) announced its first-quarter financial results, reporting a net income of $0.128 million, or $0.01 a share, compared to $7.8 million, or $0.46 a share, in the prior year quarter...

Sturm, Ruger & Co., Inc. engages in the business of designing, manufacturing, and selling firearms to domestic customers. It operates through the Firearms and Castings segments. The Firearms segment focuses on manufacturing and selling rifles, pistols, and revolvers principally to a number of federally licensed, independent wholesale distributors. The Castings segment offers steel investment castings and metal injection molding parts. The company was founded by William B. Ruger in 1949 and is headquartered in Southport, CT.

Sturm, Ruger & Co., Inc.

Smith & Wesson, Sturm, Other Gun Stocks In Focus As US Reportedly Moves To Ease Firearm Restrictions 

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>The U.S. is considering changes to the Bureau of Alcohol, Tobacco, Firearms, and Explosives regulations.</li><li>The changes, which could reportedly be announced at the National Shooting Sports Foundation trade show, which begins on Tuesday, would likely impact trading in major gun stocks.</li><li>The Donald Trump administration has previously signaled its intent to reverse many firearms restrictions implemented under his predecessor, Joe Biden.&nbsp;</li></ul>Gun stocks, including Smith &amp; Wesson Brands, Inc. and Sturm, Ruger &amp; Co.,&nbsp;are likely to gather heightened attention&nbsp;on Tuesday as the U.S. government reportedly moves to ease certain rules on local private sales and the export of firearms.The Justice Department is considering loosening a slate of gun regulations, the Washington Post&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.washingtonpost.com/national-security/2026/01/19/trump-justice-department-gun-regulations-atf/">reported</a> on late Monday, citing unnamed sources.&nbsp;The changes to the Bureau of Alcohol, Tobacco, Firearms, and Explosives regulations are expected to ease restrictions on private sales, alter the types of firearms that can be imported, and make licensing fees refundable. A requirement for disclosing gender at the time of gun purchase might also be dropped.<h2 class="st-heading-2">Stocks In Focus</h2>If done, the changes could potentially increase sales of firearms; stock such as Smith &amp; Wesson Brands (SWBI), Sturm, Ruger (RGR), American Outdoor Brands (AOUT), and GunBroker.com parent Outdoor Holding (POWW), are likely to react to the news as trading begins in the shortened week on Tuesday.On Stocktwits, retail sentiment for&nbsp;<a href="https://stocktwits.com/symbol/RGR">RGR</a> shifted to ‘bullish’ from ‘neutral’ as of late Monday, while the sentiment for&nbsp;<a href="https://stocktwits.com/symbol/AOUT">AOUT</a> shifted to ‘neutral’ from ‘bearish.’&nbsp;<a href="https://stocktwits.com/symbol/SWBI">SWBI</a>’s sentiment reading climbed higher in the ‘bullish’ zone, while that for&nbsp;<a href="https://stocktwits.com/symbol/POWW">POWW</a> remained in the ‘neutral’ zone.Stocktwits reported last month that firearm stocks&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-gun-stocks-barely-moved-in-2025-despite-mass-shootings/cLeJf0UREYr">largely underperformed</a> in 2025, although POWW gained 55% thanks to a marked improvement in its fundamentals and the ammunition manufacturing business.AOUT and RGR are leading in the new year, with 23% and 15.6% gains, respectively, already in January. Beyond regulatory shifts, the stocks also see sharp moves following mass-shooting events, as was&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/charlie-kirk-shooting-gun-stocks-jump-trump-condemns-killing/chwN5FiRdHI">observed</a> in the aftermath of the killing of conservative activist Charlie Kirk.<h2 class="st-heading-2">The Gun Laws Issue</h2>The&nbsp;Washington Post reported that officials could announce the changes to coincide with the National Shooting Sports Foundation gun trade show in Las Vegas, which begins on Tuesday.Deputy Attorney General Todd Blanche is set to address the event. The NSSF SHOT Show ranks among the largest firearms trade exhibitions in the U.S., and top Justice Department officials from both Democratic and Republican parties are typically in attendance.Gun policy has become a prominent political issue, with the Donald Trump administration signaling its intent to reverse many firearms restrictions implemented under his predecessor, Joe Biden.&nbsp;Since taking office, Trump has ordered federal agencies to review and roll back several Biden-era firearm regulations and has dismantled structures such as the White House Office of Gun Violence Prevention that focused on gun safety.&nbsp;The administration has also reversed enforcement policies like the Bureau of Alcohol, Tobacco, Firearms, and Explosives’ “zero-tolerance” dealer rule and worked to rescind other regulatory measures, moves welcomed by major gun-rights organizations such as the Gun Owners of America.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/saas-stocks-stumble-as-ai-fears-trigger-selloff-retail-eyes-selective-bets/cmUu4hVR49H">From Intuit To Adobe To Salesforce, SaaS Stocks Stumble As AI Fears Trigger Selloff — Retail Eyes Selective Bets</a>

A firearm store owner helps a buyer in n Sabattus, Maine, Friday, October 27, 2023. (Photo by Salwan Georges/The Washington Post via Getty Images)

The Justice Department is considering changes to firearm sales and exports, as well as certain other formalities.

American Outdoor Brands Inc

Outdoor Holding Company

Smith & Wesson Brands Inc

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$43.52
Prev Close	$43.38
Open	$43.78
Dividend Yield	1.90%
50-Day Moving Average	$39.87
Beta	0.39
Avg. Volume	209,501.39
PE Ratio	57.75

52-Week High	$47.50
52-Week Low	$28.33
Market Capitalization	$693.14M
EPS (Annual)	-$0.2705
Price to Book	2.37
Revenue Per Employee	$306,773.60

Feed

News

Sentiment

Earnings

Fundamentals

Info

RGR Fundamentals